In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis. (2018)

First Author: Williams AJ
Attributed to:  PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2017.10.029

PubMed Identifier: 29038066

Publication URI: http://europepmc.org/abstract/MED/29038066

Type: Journal Article/Review

Volume: 535

Parent Publication: International journal of pharmaceutics

Issue: 1-2

ISSN: 0378-5173